[ad_1]
Joint declaration plan ‘Meeting high scientific and ethical standards’
Trump administration rushes to approve vaccine
WHO “It seems difficult to market until the middle of next year”
A medical officer holds a medical syringe and an injectable vial labeled “Corona 19 Vaccine.” Reuters Yonhap News
It is reported that the main vaccine developers for the novel coronavirus infection (Corona 19) in the United States will announce a joint statement that they will not obtain government approval until the candidate vaccine is shown to be safe and effective. Amid the spread of public opinion against vaccination due to constant pressure from Donald Trump for the US administration to approve the vaccine in advance, drug companies have taken unusual group action.
The Wall Street Journal (WSJ) cited a draft joint statement being prepared by Pfizer, Johnson & Johnson, Modena, and other pharmaceutical companies developing the COVID-19 vaccine on Day 4 (local time). He said he will profess to meet the standards. According to various sources cited by WSJ, the statement will be released early next week.
This came amid growing concern that President Trump, who is seeking re-election before the US presidential election on November 3, may quickly approve a vaccine for the vote. President Trump insisted that the Corona 19 vaccine could be launched within the next month at a press conference at the White House. President Trump said: “The Corona 19 vaccine is expected to be released within this year” and “Before November 1, it is expected to be released in October.” Previously, the Centers for Disease Control and Prevention (CDC) notified each state government on the 27th of last month to prepare for distribution, as the vaccines may be available in late October or early November.
In this sense, officials of the World Health Organization (WHO) emphasized the need for rigorous controls on the effectiveness and safety of vaccines. “WHO will not support effective and unsafe vaccines,” WHO Secretary-General Thewardros Adhanom, Governor Yeosus, said at a video news conference that day. Sumya Swaminatan, WHO Chief Scientist, said: “Until regulatory authorities, governments and WHO are satisfied that minimum safety standards have been met, the vaccine should not be applied in large quantities.” It is expected to finish and enter the mass production process, but the vaccination will be available in the second or third quarter of next year. ”According to the WHO, there are 34 COVID-19 vaccines currently in clinical trials worldwide. 142 candidates They are in the preclinical stage.
Kim So-yeon reporter [email protected]
Subscribe to the Hankook Ilbo News Naver channel
Balance to see the world, the Hankook Ilbo Copyright © Hankookilbo
[ad_2]
